Rock Creek Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1985-06-01
- Employees
- 11
- Market Cap
- -
- Website
- http://starscientific.com
Safety, Tolerability, and Pharmacokinetics of Modified and Immediate Release Anatabine Citrate Formulations
Phase 1
Completed
- Conditions
- Pharmacokinetics of Anatabine
- Interventions
- Drug: Modified Release Formulation x (MRx)
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT02432313
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, United Kingdom
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
Not Applicable
Completed
- Conditions
- Rosacea
- Interventions
- Other: Placebo CreamOther: Anatabloc Cream
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT01740934
- Locations
- 🇺🇸
Susan H. Weinkle, MD, Bradenton, Florida, United States
🇺🇸Lupo Center for Aesthetic & General Dermatology, New Orleans, Louisiana, United States
🇺🇸Diane Berson, MD, New York, New York, United States
Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease
Phase 2
Terminated
- Conditions
- Alzheimer Disease
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Anatabloc(R)
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2015-04-30
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 85
- Registration Number
- NCT01669876
- Locations
- 🇺🇸
Roskamp Institute, Sarasota, Florida, United States
Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)
Phase 2
Completed
- Conditions
- Thyroiditis, Autoimmune
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Anatabloc Supplement
- First Posted Date
- 2012-03-12
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 165
- Registration Number
- NCT01551498
- Locations
- 🇺🇸
Metabolic Research Institute, Inc., West Palm Beach, Florida, United States
🇺🇸Florida Medical Clinic, P.A., Zephyrhills, Florida, United States
🇺🇸Associated Endocrinologists, P.C., West Bloomfield, Michigan, United States
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
Phase 1
Completed
- Conditions
- Tobacco Use DisorderTobacco DependenceSmoking
- Interventions
- Dietary Supplement: Anatabloc(TM)Dietary Supplement: CigRx(R)
- First Posted Date
- 2011-09-02
- Last Posted Date
- 2015-10-30
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT01428310
- Locations
- 🇺🇸
Comfort Inn, Martinsburg, West Virginia, United States
A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
Phase 1
Completed
- Conditions
- SmokingTobacco Use Disorder
- Interventions
- Dietary Supplement: CigRx LozengeOther: Tobacco Lozenge
- First Posted Date
- 2010-12-17
- Last Posted Date
- 2015-10-30
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT01262170
- Locations
- 🇺🇸
Comfort Inn, Martinsburg, West Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath